Clinical Trial Update: Efficacy and Safety Study of Fostamatinib Tablets to Treat B-cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports results from Phase 1/2 studies of fostamatinib tablets for lymphoma, with the study completed and results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• Fostamatinib (fostamatinib)

Snippet

Sponsor: Rigel Pharmaceuticals | Conditions: Lymphoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-12-18